|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3850 AUD | +2.67% |
|
+1.32% | -40.77% |
| 07-29 | Recce Pharmaceuticals in Position to Benefit from US ASPR Medical Countermeasures Strategy | MT |
| 07-21 | Recce Pharmaceuticals Reports Higher Cash Balance in June Quarter | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +2.67% | +1.32% | 0.00% | -18.95% | -40.77% | -6.10% | -46.90% | -58.15% | +54.00% | 79.31M | |
| -0.52% | +3.21% | -2.57% | +25.02% | +10.33% | +89.52% | +125.32% | +343.82% | +1,354.86% | 1,057B | |
| +0.88% | +1.13% | +0.05% | +17.13% | +25.27% | +49.56% | +49.79% | +49.24% | +110.03% | 625B | |
| +0.89% | -1.95% | -1.55% | +22.07% | +7.68% | +24.23% | +63.19% | +115.71% | +268.54% | 435B | |
| +0.34% | +3.48% | +9.45% | +15.34% | +12.25% | +49.57% | +38.03% | +0.97% | +48.85% | 363B | |
| -0.16% | +0.96% | +1.14% | +10.55% | +14.69% | +30.91% | +38.77% | +48.21% | +56.25% | 296B | |
| +0.23% | +3.79% | -7.00% | -11.60% | -13.44% | +8.16% | +6.93% | +46.47% | +131.32% | 249B | |
| +1.51% | +6.69% | +13.01% | +23.89% | +25.55% | +42.58% | +58.47% | +80.33% | +138.81% | 222B | |
| -0.80% | +0.13% | -6.07% | +0.90% | -6.93% | -6.17% | -51.49% | -4.36% | +90.14% | 209B | |
| +1.80% | +2.30% | -1.21% | +1.43% | +8.53% | +11.56% | +66.16% | +94.58% | +67.92% | 165B | |
| +2.14% | +7.00% | +10.35% | +4.21% | +7.47% | +8.87% | -25.33% | -41.80% | -23.72% | 153B | |
| +0.89% | -0.90% | +11.70% | +15.24% | +19.99% | +40.85% | +6.76% | -3.95% | +5.05% | 132B | |
| +2.49% | +3.98% | -0.09% | +15.41% | +9.42% | +35.34% | +43.74% | +147.54% | +382.42% | 126B | |
| -2.00% | +0.81% | -1.86% | +4.36% | +5.51% | +37.11% | +38.73% | +6.50% | -9.28% | 106B | |
| -0.09% | +0.99% | -1.30% | +2.76% | -9.04% | -7.50% | -23.11% | -13.09% | +5.66% | 104B | |
| +3.72% | +6.36% | -3.75% | -10.57% | -13.72% | +15.10% | +66.71% | +74.48% | +492.67% | 71.54B | |
| -0.65% | +5.03% | -1.26% | +33.47% | +33.72% | +92.49% | -6.07% | +4.65% | -49.20% | 56.57B | |
| +0.76% | +3.22% | +4.16% | +8.14% | +15.45% | +28.47% | +25.38% | +54.07% | +17.17% | 56.09B | |
| +4.82% | +1.00% | -1.78% | +3.45% | -8.31% | -10.44% | +35.84% | -4.04% | +227.78% | 53.41B | |
| -1.30% | +0.80% | +0.94% | +11.65% | -2.56% | +3.51% | +8.64% | - | - | 43.91B | |
| Average | +0.88% | +1.52% | +1.12% | +8.70% | +5.05% | +26.88% | +25.98% | +49.54% | +177.33% | 226.16B | |
| Weighted average by Cap. | +0.44% | +1.54% | +0.60% | +14.57% | +10.39% | +43.60% | +53.86% | +116.67% | +409.83% |
- Stock Market
- Stocks
- RCE Stock
- Sector Recce Pharmaceuticals Ltd
Select your edition
All financial news and data tailored to specific country editions
